Personalis, Inc. (PSNL)

USD 3.3

(8.91%)

Operating Expenses Summary of Personalis, Inc.

  • Personalis, Inc.'s latest annual operating expenses in 2023 was 128.14 Million USD , down -11.16% from previous year.
  • Personalis, Inc.'s latest quarterly operating expenses in 2024 Q1 was 24.37 Million USD , down -3.04% from previous quarter.
  • Personalis, Inc. reported a annual operating expenses of 128.88 Million USD in annual operating expenses 2022, up 32.85% from previous year.
  • Personalis, Inc. reported a annual operating expenses of 97.01 Million USD in annual operating expenses 2021, up 55.81% from previous year.
  • Personalis, Inc. reported a quarterly operating expenses of 24.37 Million USD for 2024 Q1, down -3.04% from previous quarter.
  • Personalis, Inc. reported a quarterly operating expenses of 29.98 Million USD for 2023 Q2, down -2.23% from previous quarter.

Annual Operating Expenses Chart of Personalis, Inc. (2023 - 2017)

Historical Annual Operating Expenses of Personalis, Inc. (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 128.14 Million USD -11.16%
2022 128.88 Million USD 32.85%
2021 97.01 Million USD 55.81%
2020 62.26 Million USD 39.92%
2019 44.49 Million USD 73.99%
2018 25.57 Million USD 29.04%
2017 19.82 Million USD 0.0%

Peer Operating Expenses Comparison of Personalis, Inc.

Name Operating Expenses Operating Expenses Difference
OpGen, Inc. 30.65 Million USD -317.98%
Standard BioTools Inc. 113.48 Million USD -12.913%
Aspira Women's Health Inc. 24.11 Million USD -431.409%
bioAffinity Technologies, Inc. 8.76 Million USD -1362.023%
Castle Biosciences, Inc. 242.78 Million USD 47.219%
Exact Sciences Corporation 2.06 Billion USD 93.781%
IDEXX Laboratories, Inc. 1.09 Billion USD 88.274%
Intelligent Bio Solutions Inc. 11.7 Million USD -994.425%
iSpecimen Inc. 16.27 Million USD -687.258%
Inotiv, Inc. 246.9 Million USD 48.099%
Psychemedics Corporation 11.33 Million USD -1030.616%
RadNet, Inc. 268.87 Million USD 52.341%
Prenetics Global Limited 60.73 Million USD -110.983%
Neuronetics, Inc. 82.25 Million USD -55.781%
Star Equity Holdings, Inc. 16.27 Million USD -687.512%
Exagen Inc. 52.29 Million USD -145.05%
Bionano Genomics, Inc. 148.99 Million USD 13.993%
CareDx, Inc 277.76 Million USD 53.867%
Check-Cap Ltd. 19.28 Million USD -564.406%
Twist Bioscience Corporation 354.18 Million USD 63.82%
Guardant Health, Inc. 901.62 Million USD 85.787%
Biodesix, Inc. 77.41 Million USD -65.52%
BioNexus Gene Lab Corp. 3.92 Million USD -3166.408%
Precipio, Inc. 13.63 Million USD -839.61%
Natera, Inc. 938.98 Million USD 86.353%
Fulgent Genetics, Inc. 171.9 Million USD 25.457%
Sera Prognostics, Inc. 39.91 Million USD -221.026%
23andMe Holding Co. 420.73 Million USD 69.543%
OPKO Health, Inc. 574.68 Million USD 77.702%
Aclaris Therapeutics, Inc. 110.52 Million USD -15.941%
Applied DNA Sciences, Inc. 16.48 Million USD -677.256%
T2 Biosystems, Inc. 41.49 Million USD -208.825%
Neogen Corporation 405.23 Million USD 68.378%
Myriad Genetics, Inc. 600.1 Million USD 78.646%
ICON Public Limited Company 755.64 Million USD 83.042%
NeoGenomics, Inc. 341.25 Million USD 62.449%
Star Equity Holdings, Inc. 16.27 Million USD -687.512%
MDxHealth SA 71.25 Million USD -79.836%
Prenetics Global Limited 60.73 Million USD -110.983%
Illumina, Inc. 3.81 Billion USD 96.639%
DarioHealth Corp. 62.17 Million USD -106.109%
ENDRA Life Sciences Inc. 10.52 Million USD -1118.014%
Medpace Holdings, Inc. 187.68 Million USD 31.722%
Mainz Biomed B.V. 27.15 Million USD -371.91%
Trinity Biotech plc 46.49 Million USD -175.608%
Sotera Health Company 300.46 Million USD 57.352%
bioAffinity Technologies, Inc. 8.76 Million USD -1362.023%